BioLife Solutions, Inc. (BLFS) Current Ratio
- Current ratio · latest quarter: Value 9.69×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 9.69× | Current assets / current liabilities. $135.20M ÷ $13.95M ≈ 9.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 135.20M USD | Assets, Current |
| Current obligations | 13.95M USD | Liabilities, Current |
| Cash and equivalents | 24.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 58.42M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 10.65M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 35.59M USD | Inventory, Net |
| Payables | 2.48M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $135.20M | $13.95M | $24.00M | $58.42M | $10.65M | $35.59M | $2.48M | $0.00 | 9.69× |
| 2026-03-31 | $133.22M | $18.25M | $22.82M | $58.17M | $13.06M | $32.83M | $3.75M | $2.50M | 7.30× |
| 2025-12-31 | $136.56M | $22.98M | $33.04M | $55.89M | $7.95M | $30.16M | $1.49M | $5.00M | 5.94× |
| 2025-09-30 | $126.57M | $27.15M | $29.48M | $49.47M | $10.84M | $27.82M | $2.89M | $7.49M | 4.66× |
| 2025-06-30 | $125.43M | $28.31M | $31.90M | $49.86M | $10.06M | $27.69M | $3.21M | $10.05M | 4.43× |
| 2025-03-31 | $131.13M | $27.72M | $66.94M | $21.64M | $9.17M | $27.57M | $3.30M | $10.45M | 4.73× |
| 2024-12-31 | $148.76M | $32.73M | $91.54M | $9.20M | $8.48M | $29.01M | $3.36M | $10.94M | 4.54× |
| 2024-09-30 | $89.38M | $32.17M | $23.98M | $10.21M | $17.92M | $32.18M | $3.84M | $12.23M | 2.78× |
| 2024-06-30 | $88.20M | $30.82M | $22.01M | $12.12M | $18.06M | $32.50M | $4.21M | $10.61M | 2.86× |
| 2024-03-31 | $111.70M | $38.66M | $29.69M | $15.58M | $18.57M | $43.41M | $4.98M | $8.62M | 2.89× |
| 2023-12-31 | $120.60M | $42.18M | $27.90M | $16.29M | $7.90M | $27.16M | $2.27M | $6.29M | 2.86× |
| 2023-09-30 | $116.82M | $42.62M | $19.23M | $21.79M | $24.56M | $43.35M | $11.98M | $5.03M | 2.74× |
| 2023-06-30 | $120.31M | $39.59M | $21.40M | $24.86M | $26.86M | $39.18M | $10.69M | $1.94M | 3.04× |
| 2023-03-31 | $132.79M | $47.32M | $19.11M | $35.78M | $30.34M | $41.33M | $15.53M | $1.25M | 2.81× |
| 2022-12-31 | $138.45M | $44.58M | $19.44M | $43.26M | $33.94M | $34.90M | $15.37M | $1.81M | 3.11× |
| 2022-09-30 | $136.22M | $40.42M | (m) | (m) | (m) | (m) | (m) | (m) | 3.37× |
| 2022-06-30 | $118.36M | $36.37M | (m) | (m) | (m) | (m) | (m) | (m) | 3.25× |
| 2022-03-31 | $118.97M | $37.75M | (m) | (m) | (m) | (m) | (m) | (m) | 3.15× |
| 2021-12-31 | $126.09M | $42.70M | $69.86M | $0.00 | $23.22M | $28.34M | $14.95M | $862.00K | 2.95× |
| 2021-09-30 | $130.50M | $35.79M | $75.10M | (m) | $20.23M | $29.70M | $14.30M | $1.77M | 3.65× |
| 2021-06-30 | $127.41M | $31.27M | $76.25M | (m) | $21.09M | $25.87M | $9.85M | $2.92M | 4.07× |
| 2021-03-31 | $116.54M | $16.38M | $89.01M | (m) | $10.67M | $11.67M | $4.28M | (m) | 7.11× |
| 2020-12-31 | $114.71M | $15.57M | $90.40M | (m) | $8.01M | $11.60M | $3.67M | $614.00K | 7.37× |
| 2020-09-30 | $127.78M | $8.36M | $93.98M | (m) | $6.09M | $11.04M | $2.35M | (m) | 15.28× |
| 2020-06-30 | $46.25M | $7.49M | $29.88M | (m) | $4.35M | $10.89M | $3.08M | (m) | 6.18× |
| 2020-03-31 | $26.45M | $25.46M | $6.40M | (m) | $8.21M | $10.83M | $3.52M | (m) | 1.04× |
| 2019-12-31 | $24.11M | $7.67M | $6.45M | (m) | $5.34M | $10.97M | $3.12M | (m) | 3.14× |
| 2019-09-30 | $32.07M | $5.01M | $21.20M | (m) | $4.31M | $5.69M | $1.57M | (m) | 6.40× |
| 2019-06-30 | $29.14M | $3.16M | $19.62M | (m) | $3.83M | $5.31M | $876.00K | (m) | 9.21× |
| 2019-03-31 | $39.16M | $2.70M | $31.82M | (m) | $2.93M | $4.06M | $1.26M | (m) | 14.50× |
| 2018-12-31 | $37.56M | $1.94M | $30.66M | (m) | $3.04M | $3.51M | $720.00K | (m) | 19.37× |
| 2018-09-30 | $38.29M | $2.10M | $32.38M | (m) | $2.70M | $2.91M | $1.09M | (m) | 18.28× |
| 2018-06-30 | $18.81M | $1.66M | $14.17M | (m) | $2.17M | $2.12M | $843.00K | (m) | 11.30× |
| 2018-03-31 | $10.24M | $1.31M | $7.03M | (m) | $1.04M | $1.84M | $586.00K | (m) | 7.81× |
| 2017-12-31 | $9.93M | $1.51M | $6.66M | (m) | $1.02M | $1.85M | $691.00K | (m) | 6.56× |
| 2017-09-30 | $6.37M | $1.09M | $2.83M | (m) | $1.36M | $1.86M | $420.39K | (m) | 5.84× |
| 2017-06-30 | $5.68M | $1.05M | $2.31M | (m) | $1.17M | $1.77M | $531.92K | (m) | 5.43× |
| 2017-03-31 | $5.58M | $1.09M | $2.29M | (m) | $1.06M | $1.81M | $638.01K | (m) | 5.14× |
| 2016-12-31 | $4.63M | $1.13M | $1.41M | (m) | $1.19M | $1.76M | $710.72K | (m) | 4.08× |
| 2016-09-30 | $4.97M | $3.46M | $1.37M | (m) | $1.31M | $1.90M | $1.09M | (m) | 1.43× |
| 2016-06-30 | $4.92M | $2.26M | $1.32M | (m) | $1.28M | $1.91M | $864.45K | (m) | 2.17× |
| 2016-03-31 | $5.31M | $1.48M | $1.66M | (m) | $1.19M | $2.02M | $772.87K | (m) | 3.59× |
| 2015-12-31 | $6.97M | $1.73M | $2.17M | (m) | $929.29K | $1.83M | $1.03M | (m) | 4.04× |
| 2015-09-30 | $8.28M | $1.63M | $2.35M | (m) | $792.27K | $1.78M | $978.28K | (m) | 5.08× |
| 2015-06-30 | $9.30M | $1.16M | $3.90M | (m) | $809.39K | $1.32M | $640.27K | (m) | 8.01× |
| 2015-03-31 | $10.96M | $1.46M | $2.97M | (m) | $851.04K | $1.24M | $900.35K | (m) | 7.49× |
| 2014-12-31 | $12.17M | $1.26M | $2.54M | (m) | $901.62K | $965.22K | $474.66K | (m) | 9.64× |
| 2014-09-30 | $12.83M | $833.01K | $3.28M | (m) | $775.08K | $717.62K | $168.84K | (m) | 15.41× |
| 2014-06-30 | $13.47M | $613.00K | $5.90M | (m) | $566.54K | $678.16K | $170.11K | (m) | 21.98× |
| 2014-03-31 | $14.67M | $1.06M | $12.84M | (m) | $1.33M | $297.11K | $707.98K | (m) | 13.79× |
| 2013-12-31 | $1.88M | $1.63M | $156.27K | (m) | $1.01M | $420.92K | $867.07K | (m) | 1.15× |
| 2013-09-30 | $1.66M | $1.23M | $79.29K | (m) | $1.03M | $409.19K | $840.50K | (m) | 1.35× |
| 2013-06-30 | $1.82M | $1.42M | $76.20K | (m) | $980.97K | $593.14K | $1.04M | (m) | 1.28× |
| 2013-03-31 | $1.92M | $1.47M | $61.52K | (m) | $976.16K | $676.44K | $1.05M | (m) | 1.30× |
| 2012-12-31 | $1.63M | $1.37M | $196.48K | (m) | $600.15K | $656.40K | $862.49K | (m) | 1.19× |
| 2012-09-30 | $1.78M | $1.47M | $7.53K | (m) | $797.94K | $849.21K | $1.06M | (m) | 1.21× |
| 2012-06-30 | $1.51M | $1.02M | $155.35K | (m) | $359.19K | $916.81K | $531.62K | (m) | 1.48× |
| 2012-03-31 | $1.37M | $687.81K | $70.52K | (m) | $471.82K | $763.97K | $534.00K | (m) | 2.00× |
| 2011-12-31 | $1.16M | $579.25K | $16.86K | (m) | $547.14K | $505.96K | $403.10K | (m) | 2.00× |
| 2011-09-30 | $1.04M | $516.15K | $20.12K | (m) | $458.68K | $475.13K | $310.44K | (m) | 2.02× |
| 2011-06-30 | $1.01M | $502.77K | $36.15K | (m) | $395.32K | $509.57K | (m) | (m) | 2.00× |
| 2010-12-31 | $814.97K | $340.70K | $3.21K | (m) | $338.90K | $410.49K | $117.07K | (m) | 2.39× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |